Behçet’s syndrome (BS) is a rare neutrophilic vasculitis characterized by arterial and venous events, uniquely treated by immunosuppressants rather than anticoagulants. We demonstrated in BS an impaired fibrinogen structure and fibrin susceptibility to plasmin-induced lysis, mainly due to an enhanced neutrophils reactive oxygen species (ROS) production, supporting the notion that BS is a model of inflammation-induced thrombosis .
Butyrate Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome
Emmi, GiacomoPrimo
;
2021-01-01
Abstract
Behçet’s syndrome (BS) is a rare neutrophilic vasculitis characterized by arterial and venous events, uniquely treated by immunosuppressants rather than anticoagulants. We demonstrated in BS an impaired fibrinogen structure and fibrin susceptibility to plasmin-induced lysis, mainly due to an enhanced neutrophils reactive oxygen species (ROS) production, supporting the notion that BS is a model of inflammation-induced thrombosis .File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
emmi-et-al-2020-butyrate-rich-diets-improve-redox-status-and-fibrin-lysis-in-behçet-s-syndrome.pdf
Accesso chiuso
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright Editore
Dimensione
695.83 kB
Formato
Adobe PDF
|
695.83 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
emmi-et-al-2020-butyrate-rich-diets-improve-redox-status-and-fibrin-lysis-in-behçet-s-syndrome-Post_print.pdf
accesso aperto
Tipologia:
Bozza finale post-referaggio (post-print)
Licenza:
Creative commons
Dimensione
1.26 MB
Formato
Adobe PDF
|
1.26 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
